Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Naresh Mandava

Concepts (379)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Macular Degeneration
25
2026
196
5.540
Why?
Geographic Atrophy
15
2026
105
5.130
Why?
Wet Macular Degeneration
9
2026
63
2.870
Why?
Tomography, Optical Coherence
19
2026
283
2.700
Why?
Visual Acuity
22
2026
499
2.310
Why?
Fluorescein Angiography
21
2026
197
2.240
Why?
Retinal Detachment
6
2023
74
1.880
Why?
Diabetic Retinopathy
11
2023
211
1.670
Why?
Retinal Drusen
4
2024
31
1.660
Why?
Complement System Proteins
4
2026
326
1.630
Why?
Angiogenesis Inhibitors
17
2023
239
1.590
Why?
Registries
9
2025
2400
1.510
Why?
Choroid
7
2025
81
1.440
Why?
Complement Activation
5
2025
412
1.170
Why?
Vitreous Body
16
2022
118
1.080
Why?
Vitrectomy
12
2020
74
1.000
Why?
Multimodal Imaging
2
2025
137
0.950
Why?
Macula Lutea
2
2023
21
0.940
Why?
Vascular Endothelial Growth Factor A
13
2024
545
0.940
Why?
Aged, 80 and over
24
2026
8391
0.920
Why?
Biomarkers
9
2026
4340
0.810
Why?
Retina
10
2021
330
0.800
Why?
Follow-Up Studies
19
2026
5439
0.780
Why?
Retinal Diseases
4
2023
102
0.750
Why?
Antibodies, Monoclonal
9
2011
1512
0.720
Why?
Aged
37
2026
26432
0.710
Why?
Retinal Neovascularization
2
2019
29
0.690
Why?
Choroidal Neovascularization
6
2019
57
0.670
Why?
National Eye Institute (U.S.)
1
2020
6
0.660
Why?
Retinal Perforations
4
2015
18
0.640
Why?
Quarantine
1
2020
31
0.620
Why?
Estrogen Replacement Therapy
1
2019
144
0.560
Why?
Retinitis Pigmentosa
3
2021
22
0.540
Why?
Retinopathy of Prematurity
4
2024
183
0.540
Why?
Fundus Oculi
8
2026
89
0.530
Why?
Humans
89
2026
146342
0.520
Why?
Female
57
2026
79499
0.520
Why?
Male
55
2026
73396
0.510
Why?
Disease Progression
8
2026
2867
0.500
Why?
Epiretinal Membrane
3
2010
7
0.490
Why?
Intraocular Pressure
6
2012
344
0.480
Why?
Automobile Driving
1
2018
157
0.480
Why?
Prospective Studies
10
2026
8123
0.480
Why?
Fovea Centralis
3
2025
24
0.470
Why?
Scleral Buckling
3
2019
16
0.450
Why?
Proliferating Cell Nuclear Antigen
2
2007
48
0.450
Why?
Vitreoretinopathy, Proliferative
2
2007
15
0.440
Why?
Optic Neuropathy, Ischemic
3
2013
31
0.420
Why?
RNA, Catalytic
2
2007
191
0.410
Why?
Surveys and Questionnaires
6
2026
6073
0.410
Why?
Self Report
1
2018
870
0.410
Why?
Recombinant Fusion Proteins
4
2013
663
0.390
Why?
Middle Aged
35
2026
36619
0.390
Why?
Antibodies, Monoclonal, Humanized
11
2015
992
0.380
Why?
Optic Disk
4
2025
57
0.380
Why?
Research Design
1
2019
1143
0.370
Why?
Bevacizumab
11
2015
169
0.370
Why?
Retinal Necrosis Syndrome, Acute
2
2013
7
0.350
Why?
Retrospective Studies
26
2025
17438
0.350
Why?
Retinal Vein Occlusion
2
2015
14
0.350
Why?
Image Processing, Computer-Assisted
3
2026
778
0.350
Why?
Pandemics
1
2020
1707
0.340
Why?
Photography
4
2015
120
0.340
Why?
Retinal Pigment Epithelium
3
2024
81
0.340
Why?
Uveal Diseases
2
2013
6
0.340
Why?
Endophthalmitis
3
2017
46
0.330
Why?
Colorado
8
2025
4595
0.330
Why?
Cross-Sectional Studies
8
2025
5899
0.330
Why?
Cataract
2
2020
240
0.320
Why?
Diagnostic Techniques, Ophthalmological
2
2015
55
0.310
Why?
Complement Factor B
2
2022
106
0.310
Why?
Glycogen Storage Disease Type IIb
2
2007
27
0.300
Why?
Visual Fields
3
2022
120
0.300
Why?
Vision, Low
4
2022
16
0.290
Why?
Pigment Epithelium of Eye
2
2006
36
0.290
Why?
Injections
6
2010
201
0.280
Why?
Ophthalmology
2
2013
122
0.270
Why?
Risk Factors
11
2025
10921
0.270
Why?
Ocular Hypertension
1
2009
72
0.270
Why?
Health Knowledge, Attitudes, Practice
2
2014
1408
0.270
Why?
Phacoemulsification
3
2020
124
0.260
Why?
Macular Edema
2
2015
49
0.250
Why?
Encephalitis, Herpes Simplex
1
2007
21
0.250
Why?
Optic Nerve Injuries
1
2007
9
0.250
Why?
Quantum Dots
2
2021
37
0.250
Why?
von Hippel-Lindau Disease
1
2007
12
0.250
Why?
Papilledema
1
2007
44
0.250
Why?
Glaucoma
3
2025
267
0.250
Why?
Glucocorticoids
2
2013
536
0.250
Why?
Vision Disorders
2
2022
179
0.240
Why?
Puerperal Disorders
1
2007
35
0.240
Why?
Triamcinolone Acetonide
1
2006
20
0.240
Why?
Ocular Hypotension
1
2006
10
0.240
Why?
Herpesvirus 1, Human
1
2007
87
0.230
Why?
Ciliary Body
1
2006
40
0.230
Why?
Myopia
1
2006
59
0.230
Why?
Telangiectasis
1
2005
7
0.230
Why?
Chemokine CCL5
2
2023
40
0.220
Why?
Granuloma
1
2006
96
0.220
Why?
Optical Imaging
1
2026
63
0.220
Why?
Time Factors
5
2025
7109
0.220
Why?
Sickness Impact Profile
2
2026
67
0.220
Why?
DNA, Viral
1
2007
354
0.220
Why?
Retinal Vessels
1
2005
79
0.210
Why?
Retinal Ganglion Cells
4
2022
124
0.210
Why?
Fluorocarbons
1
2005
122
0.200
Why?
Diseases in Twins
1
2024
115
0.200
Why?
Laser Therapy
2
2021
146
0.200
Why?
Birth Weight
2
2024
521
0.200
Why?
Diabetes Mellitus
2
2023
1101
0.200
Why?
Vision Tests
1
2023
22
0.200
Why?
Twins
1
2024
156
0.200
Why?
Temporal Arteries
2
2015
45
0.200
Why?
Receptors, Vascular Endothelial Growth Factor
3
2013
109
0.190
Why?
Hemianopsia
1
2022
11
0.190
Why?
Disease Models, Animal
4
2012
4580
0.180
Why?
Ophthalmoscopy
2
2015
38
0.170
Why?
Posterior Capsulotomy
1
2021
8
0.170
Why?
Longitudinal Studies
2
2026
3017
0.170
Why?
Posterior Capsule of the Lens
1
2021
11
0.170
Why?
Capsule Opacification
1
2021
22
0.170
Why?
Lasers, Solid-State
1
2021
22
0.170
Why?
Ranibizumab
5
2013
21
0.160
Why?
Posterior Capsular Rupture, Ocular
1
2020
6
0.160
Why?
Herpesvirus 3, Human
2
2015
342
0.160
Why?
Reproducibility of Results
3
2025
3416
0.150
Why?
Nerve Fibers
2
2010
105
0.150
Why?
Artificial Intelligence
1
2025
389
0.150
Why?
Neurodegenerative Diseases
1
2022
147
0.150
Why?
Electrodes, Implanted
2
2018
114
0.150
Why?
Machine Learning
1
2026
594
0.150
Why?
Intravitreal Injections
6
2020
73
0.150
Why?
Quality of Life
5
2026
3200
0.150
Why?
Protective Factors
1
2019
97
0.150
Why?
Odds Ratio
2
2019
1077
0.150
Why?
Complement Membrane Attack Complex
1
2019
38
0.150
Why?
Ischemia
2
2017
421
0.150
Why?
Complement C3a
1
2019
40
0.140
Why?
C-Reactive Protein
1
2021
429
0.140
Why?
Intraoperative Complications
1
2020
157
0.140
Why?
Visual Prosthesis
1
2018
1
0.140
Why?
Cohort Studies
5
2020
6077
0.130
Why?
Metformin
1
2021
328
0.130
Why?
Orbit
2
2010
67
0.130
Why?
Anterior Eye Segment
1
2017
10
0.130
Why?
Labor, Induced
1
2017
41
0.120
Why?
Gestational Age
4
2024
990
0.120
Why?
Labor, Obstetric
1
2017
67
0.120
Why?
Giant Cell Arteritis
2
2015
48
0.120
Why?
Strabismus
1
2017
71
0.120
Why?
Laser Coagulation
3
2012
80
0.120
Why?
Postoperative Complications
3
2021
3034
0.120
Why?
Retinal Degeneration
2
2015
40
0.120
Why?
Ophthalmologic Surgical Procedures
1
2017
91
0.120
Why?
Blindness
3
2013
51
0.110
Why?
Gyrate Atrophy
1
2015
2
0.110
Why?
Phenotype
3
2022
3206
0.110
Why?
Immunosuppressive Agents
2
2013
829
0.110
Why?
Multivariate Analysis
1
2019
1543
0.110
Why?
Vitreoretinal Surgery
1
2015
4
0.110
Why?
Case-Control Studies
2
2020
3647
0.110
Why?
Vitreous Detachment
1
2015
6
0.110
Why?
Recovery of Function
1
2019
725
0.110
Why?
Needles
1
2015
61
0.110
Why?
Encephalitis, Varicella Zoster
1
2015
17
0.110
Why?
Incidence
2
2020
2936
0.110
Why?
Biopsy, Needle
1
2015
183
0.110
Why?
Eye Infections, Bacterial
1
2015
46
0.110
Why?
Rats, Inbred BN
3
2011
56
0.100
Why?
Antiviral Agents
2
2013
779
0.100
Why?
Logistic Models
1
2019
2126
0.100
Why?
Proteins
1
2020
1022
0.100
Why?
Wounds, Gunshot
2
2010
262
0.100
Why?
Treatment Outcome
7
2021
11821
0.100
Why?
Oculomotor Muscles
1
2014
86
0.100
Why?
Inflammation
3
2023
2919
0.100
Why?
Anti-Inflammatory Agents
2
2021
474
0.100
Why?
Drug Packaging
2
2011
41
0.100
Why?
Uvea
1
2013
4
0.100
Why?
Exchange Transfusion, Whole Blood
1
2013
18
0.100
Why?
Uveomeningoencephalitic Syndrome
1
2013
7
0.100
Why?
Fibrin
1
2014
84
0.100
Why?
Retinal Artery Occlusion
1
2013
10
0.100
Why?
Drug Resistance, Multiple, Viral
1
2013
10
0.100
Why?
Tendons
1
2014
136
0.100
Why?
Proteomics
1
2020
1203
0.100
Why?
Cytomegalovirus Retinitis
1
2013
22
0.100
Why?
Isoxazoles
1
2013
57
0.090
Why?
Lymphoproliferative Disorders
1
2013
59
0.090
Why?
Premature Birth
1
2017
390
0.090
Why?
Silicon
1
2012
19
0.090
Why?
Fatty Acids, Omega-3
1
2014
145
0.090
Why?
Lens Subluxation
1
2012
4
0.090
Why?
Trabecular Meshwork
1
2013
74
0.090
Why?
Viremia
1
2013
158
0.090
Why?
Adult
15
2020
41087
0.090
Why?
Exanthema
1
2013
86
0.090
Why?
Uveitis, Posterior
1
2012
12
0.090
Why?
Electric Stimulation Therapy
1
2012
63
0.090
Why?
Fluocinolone Acetonide
1
2012
14
0.090
Why?
Diagnostic Imaging
1
2015
340
0.090
Why?
Diagnosis, Differential
4
2013
1503
0.090
Why?
Microsurgery
1
2012
75
0.090
Why?
Placenta
1
2018
794
0.080
Why?
Vascular Endothelial Growth Factors
1
2011
77
0.080
Why?
Fluorescein-5-isothiocyanate
2
2009
34
0.080
Why?
Electroretinography
2
2012
51
0.080
Why?
Drug Storage
1
2011
52
0.080
Why?
Dextrans
2
2009
83
0.080
Why?
Particulate Matter
2
2011
328
0.080
Why?
Global Health
1
2014
403
0.080
Why?
Dissection
1
2011
58
0.080
Why?
Health Care Costs
1
2014
423
0.080
Why?
Silicone Oils
1
2011
42
0.080
Why?
Antioxidants
1
2014
544
0.080
Why?
Infliximab
2
2007
107
0.080
Why?
Lysosomal-Associated Membrane Protein 2
2
2007
32
0.080
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
1
2014
449
0.080
Why?
Protein Multimerization
1
2011
201
0.080
Why?
Clinical Trials, Phase II as Topic
1
2009
74
0.070
Why?
Bacteria
1
2015
766
0.070
Why?
Clinical Trials, Phase I as Topic
1
2009
49
0.070
Why?
Anemia, Sickle Cell
1
2013
324
0.070
Why?
Herpes Zoster
1
2013
318
0.070
Why?
Tonometry, Ocular
1
2009
107
0.070
Why?
Scotoma
1
2008
6
0.070
Why?
Rats
4
2012
5586
0.070
Why?
United States
3
2020
16136
0.070
Why?
Interleukin 1 Receptor Antagonist Protein
1
2009
253
0.070
Why?
Algorithms
2
2026
1849
0.070
Why?
Retinal Artery
1
2007
17
0.070
Why?
Vitreous Hemorrhage
1
2007
10
0.060
Why?
Cerebral Angiography
1
2007
121
0.060
Why?
RNA, Messenger
2
2007
2791
0.060
Why?
Acyclovir
1
2007
97
0.060
Why?
Dose-Response Relationship, Drug
2
2009
2022
0.060
Why?
Frameshift Mutation
1
2006
32
0.060
Why?
Conjunctival Neoplasms
1
2005
9
0.060
Why?
Internationality
2
2018
156
0.060
Why?
Ultrasonography
2
2007
788
0.060
Why?
Secondary Prevention
1
2007
248
0.060
Why?
Eye Injuries, Penetrating
1
2005
19
0.060
Why?
Indocyanine Green
1
2005
43
0.060
Why?
Eye Foreign Bodies
1
2005
23
0.060
Why?
beta-Thalassemia
1
2006
40
0.060
Why?
Coloring Agents
1
2005
88
0.060
Why?
Animals
7
2014
38106
0.060
Why?
Eye Injuries
1
2006
53
0.060
Why?
Tumor Necrosis Factor-alpha
2
2007
1224
0.060
Why?
Staining and Labeling
1
2005
148
0.060
Why?
Uncertainty
1
2026
145
0.050
Why?
Infant, Newborn
3
2024
6460
0.050
Why?
Uveitis
1
2006
152
0.050
Why?
Antihypertensive Agents
1
2009
519
0.050
Why?
Mydriatics
1
2004
10
0.050
Why?
Metals
1
2005
137
0.050
Why?
Pupil
1
2004
21
0.050
Why?
Pregnancy
3
2018
7230
0.050
Why?
Polymerase Chain Reaction
1
2007
1031
0.050
Why?
Sclera
2
2014
39
0.050
Why?
Hospitals, County
1
2023
11
0.050
Why?
Cardiomyopathy, Dilated
1
2007
357
0.050
Why?
Sensitivity and Specificity
2
2008
1998
0.050
Why?
Image Interpretation, Computer-Assisted
1
2026
295
0.050
Why?
Observer Variation
1
2004
356
0.050
Why?
Enzyme-Linked Immunosorbent Assay
2
2019
846
0.050
Why?
Fibroblasts
2
2013
1034
0.050
Why?
Proportional Hazards Models
1
2026
1331
0.050
Why?
Chimera
1
2002
62
0.050
Why?
Interleukin-4
1
2023
207
0.050
Why?
Enzyme Stability
1
2002
74
0.050
Why?
Complement Factor I
1
2022
12
0.050
Why?
Endopeptidases
1
2002
80
0.050
Why?
Preventive Medicine
1
2002
38
0.050
Why?
Double-Blind Method
1
2007
2070
0.050
Why?
Young Adult
6
2019
14330
0.050
Why?
Aqueous Humor
1
2022
41
0.040
Why?
Blood
1
2002
107
0.040
Why?
Autoimmune Diseases
1
2006
467
0.040
Why?
Coculture Techniques
1
2002
245
0.040
Why?
Albumins
1
2022
120
0.040
Why?
Retreatment
2
2012
79
0.040
Why?
Rabbits
1
2002
651
0.040
Why?
Fibrinogen
1
2022
182
0.040
Why?
Lenses, Intraocular
1
2021
49
0.040
Why?
Cell Division
1
2002
736
0.040
Why?
Cells, Cultured
2
2013
4118
0.040
Why?
Equipment Design
2
2014
520
0.040
Why?
Drug Compounding
2
2011
106
0.040
Why?
Electric Stimulation
1
2021
273
0.040
Why?
Immunologic Factors
1
2022
244
0.040
Why?
Chronic Disease
1
2006
1827
0.040
Why?
Cell Survival
2
2013
1105
0.040
Why?
Melanoma
1
2005
765
0.040
Why?
Postoperative Period
1
2019
355
0.030
Why?
Immunity, Maternally-Acquired
1
2018
18
0.030
Why?
Combined Modality Therapy
2
2013
1271
0.030
Why?
Infant
3
2020
10114
0.030
Why?
Primary Health Care
1
2008
1776
0.030
Why?
Prevalence
2
2015
2861
0.030
Why?
Iris Diseases
1
2017
7
0.030
Why?
Choroid Diseases
1
2017
10
0.030
Why?
Lipids
1
2002
714
0.030
Why?
Prosthesis Implantation
1
2018
156
0.030
Why?
Parity
1
2017
113
0.030
Why?
Infant, Low Birth Weight
1
2017
154
0.030
Why?
Sex Characteristics
1
2022
801
0.030
Why?
Referral and Consultation
1
2022
881
0.030
Why?
Mental Health
1
2022
779
0.030
Why?
Microbiological Techniques
1
2015
30
0.030
Why?
Risk
1
2018
920
0.030
Why?
Colony Count, Microbial
1
2015
90
0.030
Why?
Endotamponade
1
2015
3
0.030
Why?
Myopia, Degenerative
1
2015
5
0.030
Why?
Tenon Capsule
1
2014
3
0.030
Why?
Tissue Adhesions
1
2015
32
0.030
Why?
Cerebral Arterial Diseases
1
2015
50
0.030
Why?
Conjunctiva
1
2014
52
0.030
Why?
Atrophy
1
2015
199
0.030
Why?
Biometry
1
2014
67
0.030
Why?
Lens Implantation, Intraocular
1
2015
80
0.030
Why?
Adolescent
3
2012
22557
0.030
Why?
Fetus
1
2018
800
0.020
Why?
Early Diagnosis
1
2014
251
0.020
Why?
T-Lymphocytes
1
2022
2012
0.020
Why?
Safety-net Providers
1
2014
133
0.020
Why?
Adaptation, Ocular
1
2012
6
0.020
Why?
Dark Adaptation
1
2012
13
0.020
Why?
Rats, Mutant Strains
1
2012
19
0.020
Why?
Sclerostomy
1
2012
4
0.020
Why?
Infant, Premature
1
2017
622
0.020
Why?
Cytomegalovirus
1
2013
172
0.020
Why?
Cell Count
1
2012
315
0.020
Why?
Child, Preschool
1
2007
11913
0.020
Why?
Mothers
1
2018
772
0.020
Why?
Drug Implants
1
2012
83
0.020
Why?
Hypoglycemic Agents
1
2021
1412
0.020
Why?
Gold
1
2012
118
0.020
Why?
Bruch Membrane
1
2011
8
0.020
Why?
Swine
1
2014
821
0.020
Why?
Polyglycolic Acid
1
2011
44
0.020
Why?
Miniaturization
1
2011
22
0.020
Why?
Administration, Oral
1
2013
872
0.020
Why?
Drug Stability
1
2011
172
0.020
Why?
Delayed-Action Preparations
1
2011
192
0.020
Why?
Chromatography, Gel
1
2010
131
0.020
Why?
Fluorescein
1
2010
23
0.020
Why?
Immunoglobulin Light Chains
1
2010
52
0.020
Why?
Immunoglobulin Heavy Chains
1
2010
83
0.020
Why?
Molecular Weight
1
2010
295
0.020
Why?
Comorbidity
1
2015
1665
0.020
Why?
Electrophoresis, Polyacrylamide Gel
1
2010
326
0.020
Why?
Microfluidic Analytical Techniques
1
2010
80
0.020
Why?
Aptamers, Nucleotide
1
2010
88
0.020
Why?
Lactic Acid
1
2011
295
0.020
Why?
Particle Size
1
2011
386
0.020
Why?
Reference Values
1
2010
796
0.020
Why?
Poverty Areas
1
2008
43
0.020
Why?
Community Health Centers
1
2008
59
0.020
Why?
Optic Nerve Diseases
1
2008
49
0.020
Why?
Fluorescent Dyes
1
2010
340
0.020
Why?
Kaplan-Meier Estimate
1
2010
970
0.020
Why?
Models, Biological
1
2015
1761
0.020
Why?
Kidney Transplantation
1
2013
735
0.020
Why?
Polyethylene Glycols
1
2011
650
0.010
Why?
Pilot Projects
1
2012
1888
0.010
Why?
Imaging, Three-Dimensional
1
2010
582
0.010
Why?
Pedigree
1
2007
512
0.010
Why?
Infusions, Intravenous
1
2006
432
0.010
Why?
Adrenal Cortex Hormones
1
2008
486
0.010
Why?
Anti-Bacterial Agents
1
2015
1942
0.010
Why?
Severity of Illness Index
1
2011
2921
0.010
Why?
Mass Screening
1
2008
1307
0.010
Why?
Tomography, X-Ray Computed
1
2010
2786
0.010
Why?
Risk Assessment
1
2008
3712
0.010
Why?
Diabetes Mellitus, Type 2
1
2012
2623
0.010
Why?
Aging
1
2008
1996
0.010
Why?
Mutation
1
2007
4093
0.010
Why?
Child
1
2012
22693
0.010
Why?
Mandava's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)